Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | PRKCI | P41743 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SYK | P43405 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL278964 | 0.85 | LMNA (0.41) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL29738718 | 0.85 | LMNA (0.41) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL18401547 | 0.83 | KIF11 (0.36) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL12553833 | 0.79 | NOS3 (0.39) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL2609325 | 0.79 | NOS3 (0.53) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL17808267 | 0.79 | NOS3 (0.39) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL24132435 | 0.79 | KIF11 (0.36) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL17194955 | 0.79 | LMNA (0.41) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL14349599 | 0.79 | NOS3 (0.39) | LMNASMN1; SMN2NPC1RAB9AHTT | |
| SCHEMBL18532099 | 0.78 | ALDH1A1 (0.40) | LMNASMN1; SMN2NPC1RAB9AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220223796-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT CONTAINING ORGANIC COMPOUND, AND ELECTRONIC DEVICE | EXOC1, EXOC4, CHRM1 | LMNA 621/4885SMN1; SMN2 2691/4885NPC1 3674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.